全文获取类型
收费全文 | 55585篇 |
免费 | 4181篇 |
国内免费 | 675篇 |
专业分类
耳鼻咽喉 | 283篇 |
儿科学 | 2529篇 |
妇产科学 | 1936篇 |
基础医学 | 4441篇 |
口腔科学 | 579篇 |
临床医学 | 5969篇 |
内科学 | 14491篇 |
皮肤病学 | 860篇 |
神经病学 | 3586篇 |
特种医学 | 860篇 |
外科学 | 5612篇 |
综合类 | 3072篇 |
现状与发展 | 1篇 |
一般理论 | 17篇 |
预防医学 | 8228篇 |
眼科学 | 1702篇 |
药学 | 2541篇 |
4篇 | |
中国医学 | 489篇 |
肿瘤学 | 3241篇 |
出版年
2024年 | 56篇 |
2023年 | 574篇 |
2022年 | 338篇 |
2021年 | 764篇 |
2020年 | 686篇 |
2019年 | 365篇 |
2018年 | 1116篇 |
2017年 | 1084篇 |
2016年 | 1248篇 |
2015年 | 1191篇 |
2014年 | 1127篇 |
2013年 | 1608篇 |
2012年 | 3548篇 |
2011年 | 4886篇 |
2010年 | 2149篇 |
2009年 | 1796篇 |
2008年 | 3989篇 |
2007年 | 3890篇 |
2006年 | 3482篇 |
2005年 | 3716篇 |
2004年 | 4884篇 |
2003年 | 4735篇 |
2002年 | 3491篇 |
2001年 | 2545篇 |
2000年 | 1045篇 |
1999年 | 828篇 |
1998年 | 758篇 |
1997年 | 615篇 |
1996年 | 364篇 |
1995年 | 237篇 |
1994年 | 263篇 |
1993年 | 281篇 |
1992年 | 291篇 |
1991年 | 237篇 |
1990年 | 195篇 |
1989年 | 171篇 |
1988年 | 165篇 |
1987年 | 134篇 |
1986年 | 152篇 |
1985年 | 104篇 |
1984年 | 85篇 |
1983年 | 80篇 |
1982年 | 85篇 |
1981年 | 87篇 |
1980年 | 77篇 |
1979年 | 64篇 |
1978年 | 72篇 |
1975年 | 57篇 |
1974年 | 55篇 |
1973年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
961.
962.
963.
964.
965.
Higher maternal serum concentrations of nicotinamide and related metabolites in late pregnancy are associated with a lower risk of offspring atopic eczema at age 12 months
下载免费PDF全文
![点击此处可从《Clinical and experimental allergy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
966.
Brain disorders associated with corticotropin‐releasing hormone expression in the placenta among children born before the 28th week of gestation
下载免费PDF全文
![点击此处可从《Acta paediatrica (Oslo, Norway : 1992)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
967.
968.
Breton M Farret A Bruttomesso D Anderson S Magni L Patek S Dalla Man C Place J Demartini S Del Favero S Toffanin C Hughes-Karvetski C Dassau E Zisser H Doyle FJ De Nicolao G Avogaro A Cobelli C Renard E Kovatchev B;on behalf of The International Artificial Pancreas 《Diabetes》2012,61(9):2230-2237
Integrated closed-loop control (CLC), combining continuous glucose monitoring (CGM) with insulin pump (continuous subcutaneous insulin infusion [CSII]), known as artificial pancreas, can help optimize glycemic control in diabetes. We present a fundamental modular concept for CLC design, illustrated by clinical studies involving 11 adolescents and 27 adults at the Universities of Virginia, Padova, and Montpellier. We tested two modular CLC constructs: standard control to range (sCTR), designed to augment pump plus CGM by preventing extreme glucose excursions; and enhanced control to range (eCTR), designed to truly optimize control within near normoglycemia of 3.9-10 mmol/L. The CLC system was fully integrated using automated data transfer CGM→algorithm→CSII. All studies used randomized crossover design comparing CSII versus CLC during identical 22-h hospitalizations including meals, overnight rest, and 30-min exercise. sCTR increased significantly the time in near normoglycemia from 61 to 74%, simultaneously reducing hypoglycemia 2.7-fold. eCTR improved mean blood glucose from 7.73 to 6.68 mmol/L without increasing hypoglycemia, achieved 97% in near normoglycemia and 77% in tight glycemic control, and reduced variability overnight. In conclusion, sCTR and eCTR represent sequential steps toward automated CLC, preventing extremes (sCTR) and further optimizing control (eCTR). This approach inspires compelling new concepts: modular assembly, sequential deployment, testing, and clinical acceptance of custom-built CLC systems tailored to individual patient needs. 相似文献
969.
970.
Background: Current guidelines regarding the use of intravenous morphine (IM) in the management of patients with acute decompensated heart failure (ADHF) are discordant; whereas the American guidelines reserve IM for terminal patients, the European guidelines recommend its use in the early stage of treatment. Our aim was to determine the impact of IM on outcomes of ADHF patients. Methods: Stepwise logistic regression and propensity score analysis of ADHF patients with and without use of IM was performed in a national heart failure survey. Results: Of the 4102 enrolled patients, we identified 2336 ADHF patients, of whom 218 (9.3%) received IM. IM patients were more likely to have acute coronary syndromes, acute rather than exacerbation of chronic heart failure, and diabetes mellitus and dyslipidemia. They had higher heart rate, were less likely to receive diuretics and more likely to receive aspirin and statins. Unadjusted in-hospital mortality rates were 11.5% versus 5.0% for patients who did or did not receive IM, and the adjusted odds ratio (OR) for in-hospital death was: 2.0 (1.1–3.5, P = 0.02). Using propensity analysis, we identified 218 matched pairs of patients who did or did not receive IM. In multivariable analysis accounting for the propensity score (c-statistic 0.82), IM was not associated with increased in-hospital death (OR: 1.2 (0.6–2.4), P = 0.55). Conclusion: IM was used sparingly in our ADHF cohort, and was independently associated with increased in-hospital death in multivariable analysis, but not in propensity score analysis. Thus, IM may be used in ADHF, but with caution. Further randomized trials are warranted. 相似文献